A new member at the table: Granzyme K as a lymphocyte‐born complement initiator
Fuente:
Wiley Open Access
Guardado en:
| Autor principal: | Manoj Kumar Pandey |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Invited letter MUC4 mutations as an amplifier of complement‐mediated thrombosis in paroxysmal nocturnal haemoglobinuria
por: Eng Soo Yap, et al.
Publicado: (2026)
por: Eng Soo Yap, et al.
Publicado: (2026)
A new metabolic signature to predict melanoma recurrence
por: Ngan K. Vu, et al.
Publicado: (2024)
por: Ngan K. Vu, et al.
Publicado: (2024)
Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
por: Xinni Chen, et al.
Publicado: (2026)
por: Xinni Chen, et al.
Publicado: (2026)
Sweat exosomes: A new cutting edge nanomedicine in cancer treatment
por: Bikram Dhara, et al.
Publicado: (2024)
por: Bikram Dhara, et al.
Publicado: (2024)
Stereo cell: A new approach to the next generation of clinical precision medicine
por: Wanxin Duan, et al.
Publicado: (2025)
por: Wanxin Duan, et al.
Publicado: (2025)
GPR183 ‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer
por: Ling Ye, et al.
Publicado: (2026)
por: Ling Ye, et al.
Publicado: (2026)
Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
por: Swastika Maitra, et al.
Publicado: (2024)
por: Swastika Maitra, et al.
Publicado: (2024)
Exploring new frontiers in lung cancer treatment: The role of cancer‐associated fibroblasts (CAFs) and EGFR‐TKI resistance
por: Jiaqi Liang, et al.
Publicado: (2025)
por: Jiaqi Liang, et al.
Publicado: (2025)
Liquid biopsy—A biomarker‐based revolutionising technique in cancer therapy
por: Subham Sarkar, et al.
Publicado: (2024)
por: Subham Sarkar, et al.
Publicado: (2024)
Heterogeneous nuclear ribonucleoprotein A2/B1, a key regulator of myocardial fibrosis
por: Ji‐Hoon Jeong, et al.
Publicado: (2024)
por: Ji‐Hoon Jeong, et al.
Publicado: (2024)
Intrarenal pressure monitoring via flexible and navigable suction ureteral access sheath in retrograde intrarenal surgery: A preclinical animal study and a pilot clinical study
por: Wei Zhu, et al.
Publicado: (2025)
por: Wei Zhu, et al.
Publicado: (2025)
Beyond the paradox: Cardiac‐specific miR‐106a delivery as a translational turning point for heart failure?
por: Wei‐Wen Lim
Publicado: (2025)
por: Wei‐Wen Lim
Publicado: (2025)
The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy
por: Jing Zhao, et al.
Publicado: (2025)
por: Jing Zhao, et al.
Publicado: (2025)
Nanomedicine: a frontier of the breast cancer treatment
por: Swarup Sonar, et al.
Publicado: (2024)
por: Swarup Sonar, et al.
Publicado: (2024)
Therapeutic potential of the annexin A family in atherosclerosis
por: Suha Jarad, et al.
Publicado: (2025)
por: Suha Jarad, et al.
Publicado: (2025)
Plant‐derived exosomes: A Green Nanomedicine for Cancer
por: Swarup Sonar, et al.
Publicado: (2024)
por: Swarup Sonar, et al.
Publicado: (2024)
Plant exosomes: A natural medicine for oral cancer
por: Sidhanti Nyahatkar, et al.
Publicado: (2024)
por: Sidhanti Nyahatkar, et al.
Publicado: (2024)
Unveiling a novel cellular stress response mechanism to photodamage
por: Naibedya Dutta, et al.
Publicado: (2024)
por: Naibedya Dutta, et al.
Publicado: (2024)
A novel mechanism for maintaining spindle normality in mammalian oocytes
por: Zhi‐Xia Yang, et al.
Publicado: (2025)
por: Zhi‐Xia Yang, et al.
Publicado: (2025)
A snapshot of the role of estrogen‐regulated divergent non‐coding transcripts
por: Barbara Yang, et al.
Publicado: (2025)
por: Barbara Yang, et al.
Publicado: (2025)
CEACAM6: A potential prognostic biomarker and therapeutic target in cholangiocarcinoma
por: Jia‐Qi Guo, et al.
Publicado: (2026)
por: Jia‐Qi Guo, et al.
Publicado: (2026)
Clinical and translational research on cancer of the stomach and gastroesophageal junction: A pathologist's view
por: Christoph Röcken
Publicado: (2024)
por: Christoph Röcken
Publicado: (2024)
Targeting autophagy: A promising approach for the treatment of breast cancer brain metastases
por: Steffan T. Nawrocki, et al.
Publicado: (2024)
por: Steffan T. Nawrocki, et al.
Publicado: (2024)
Utilisation of a national database to characterise renal function in patients with COVID19 infection
por: Nicholas R. Nelson, et al.
Publicado: (2025)
por: Nicholas R. Nelson, et al.
Publicado: (2025)
Established a therapeutic response prediction model in metastatic gastric cancer by liquid biopsy
por: Sheng Liu, et al.
Publicado: (2024)
por: Sheng Liu, et al.
Publicado: (2024)
Bacterial surface derived extracellular vesicles: A ground‐breaking approach in cancer therapy
por: Asmit Das, et al.
Publicado: (2024)
por: Asmit Das, et al.
Publicado: (2024)
Tumor and cancer stem cells‐derived exosomes interplay: A secret of cancer complications
por: Swarup Sonar, et al.
Publicado: (2024)
por: Swarup Sonar, et al.
Publicado: (2024)
Senescence as a pathogenic driver in chronic kidney disease: From cellular fate to clinical stratification
por: Samuel Chauvin, et al.
Publicado: (2025)
por: Samuel Chauvin, et al.
Publicado: (2025)
Roads diverged in a wood: Proteins and RNAs encoded by cytochrome b (CYTB) gene in health and disease
por: Cijie Du, et al.
Publicado: (2025)
por: Cijie Du, et al.
Publicado: (2025)
From channel‐spatial attention to state space models: A review of evolving mechanisms in tumour segmentation
por: Yanfei Sun, et al.
Publicado: (2026)
por: Yanfei Sun, et al.
Publicado: (2026)
Gastric cancer detection based on cell‐free DNA in blood: A systematic review and meta‐analysis
por: Mona Wang, et al.
Publicado: (2024)
por: Mona Wang, et al.
Publicado: (2024)
The emerging role of CAMK1D in diabetes, metabolism and feeding behaviours: A mechanistic systematic review
por: Livio Tarchi, et al.
Publicado: (2026)
por: Livio Tarchi, et al.
Publicado: (2026)
Prediction factors and models for chronic kidney disease in type 2 diabetes mellitus: A review of the literature
por: Yan Yang, et al.
Publicado: (2024)
por: Yan Yang, et al.
Publicado: (2024)
Drug Sensitivity patterns across FAB subtypes and molecular mutations in AML: A comprehensive analysis for precision medicine
por: Mobina Shrestha, et al.
Publicado: (2025)
por: Mobina Shrestha, et al.
Publicado: (2025)
Probe‐capture targeted next‐generation sequencing: A novel approach for pathogen and antimicrobial resistance detection in sepsis
por: Chitra Ravi, et al.
Publicado: (2025)
por: Chitra Ravi, et al.
Publicado: (2025)
High expression of miR5700 in atypical type A thymoma and its role in promoting tumour progression
por: Li Zhao, et al.
Publicado: (2026)
por: Li Zhao, et al.
Publicado: (2026)
Physiology, pathology and therapeutic potential of microglial triggering receptor expressed on myeloid cells 2 signalling: A narrative update
por: Zhe Kong, et al.
Publicado: (2026)
por: Zhe Kong, et al.
Publicado: (2026)
Tumour hepcidin levels as a biomarker for predicting response to immune checkpoint inhibition in advanced non‐small cell lung cancer
por: Yuichiro Suzukawa, et al.
Publicado: (2026)
por: Yuichiro Suzukawa, et al.
Publicado: (2026)
A vital step toward targeting lymph node metastasis: Identifying APOE− cells as prognostic drivers in papillary thyroid carcinoma
por: Ling Xiao, et al.
Publicado: (2025)
por: Ling Xiao, et al.
Publicado: (2025)
scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
por: Fansen Ji, et al.
Publicado: (2025)
por: Fansen Ji, et al.
Publicado: (2025)
Ejemplares similares
-
Invited letter MUC4 mutations as an amplifier of complement‐mediated thrombosis in paroxysmal nocturnal haemoglobinuria
por: Eng Soo Yap, et al.
Publicado: (2026) -
A new metabolic signature to predict melanoma recurrence
por: Ngan K. Vu, et al.
Publicado: (2024) -
Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
por: Xinni Chen, et al.
Publicado: (2026) -
Sweat exosomes: A new cutting edge nanomedicine in cancer treatment
por: Bikram Dhara, et al.
Publicado: (2024) -
Stereo cell: A new approach to the next generation of clinical precision medicine
por: Wanxin Duan, et al.
Publicado: (2025)